Three Scientists Share 2026 Nobel Medicine Prize for Optogenetics Breakthrough

The 2026 Nobel Prize in Physiology or Medicine has been awarded to three researchers whose work created a revolutionary method for controlling nerve cells with light, a technique that has transformed how scientists study the brain. American neuroscientist Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel will share the honour, the Nobel Assembly at Sweden's Karolinska Institute announced on Monday.

The three laureates were recognised "for their discovery of a molecular switch for nerve cells," according to the citation. Their combined discoveries laid the foundation for optogenetics, a field that allows researchers to turn individual nerve cells on or off using pulses of light, giving unprecedented insight into the inner workings of the brain.

The Nobel Assembly praised the technique's sweeping impact on neuroscience. In its statement, the assembly said optogenetics "has fundamentally altered our understanding of the brain," adding that each day brings fresh discoveries that help unravel "one of humanity's great mysteries: how our incredible brain works."

Optogenetics works by introducing light-sensitive proteins into specific neurons, enabling scientists to control their activity with remarkable precision. This approach allows researchers to observe how particular cell types contribute to behaviours and functions such as learning, fear, addiction and movement. Rather than relying on broad electrical stimulation, the method offers a targeted way to probe the brain's complex circuitry.

Thomas Perlmann, secretary-general of the Nobel Assembly, explained the significance of the technique in practical terms. He said optogenetics "makes it possible to switch on, or off, the activity of individual nerve cells in a living brain." Perlmann noted that the method is now employed in laboratories worldwide, where it continues to reveal the brain's mysteries.

Per Svenningsson, who chairs the Nobel committee, emphasised the technique's transformative power for brain research. In a statement, Svenningsson said optogenetics "provides opportunities for mapping the brain in a way that we could once only dream of." His remark underscored how the discovery has opened doors that were previously closed to neuroscientists.

Beyond its use in basic research, optogenetics may have practical medical applications. Researchers hope the technique could eventually improve cochlear implants, the devices that restore hearing for people with severe hearing loss. Optogenetics could allow more precise stimulation of the auditory nerve than the electrical devices currently in use, potentially offering better outcomes for patients.

The three winners bring complementary expertise to the field. Deisseroth, 54, is a professor at Stanford University in the United States and is widely regarded as a pioneer in optogenetics. Hegemann, 71, is a neuroscience professor at Humboldt University of Berlin, while Nagel, 73, is a biophysics professor at the University of Wurzburg. Their combined work bridged molecular biology, neuroscience and biophysics.

According to the Nobel Assembly, the three scientists will split a prize sum of 12 million Swedish crowns, equivalent to roughly 1.2 million US dollars. The award recognises not only their individual contributions but also the collaborative spirit that has driven the field forward.

Speaking after the announcement, Perlmann described the winners' reactions with warmth. He said all three expressed the same sentiment: that receiving the prize alongside the other two, whom they consider friends, was "absolutely wonderful." Perlmann added that the laureates described it as "such an honour to receive the prize together," highlighting the camaraderie among the researchers.

The medicine prize is the first of this year's Nobel awards to be revealed. The winners of the prizes in physics, chemistry, literature, peace and economics will be announced over the course of the week. Among these, the peace prize attracts particular global attention because it is the only Nobel awarded in Oslo, Norway, rather than in Stockholm, Sweden.

This year's peace prize may be especially closely watched. Experts have suggested that the jury could select a laureate who enjoys broad consensus, following last year's controversial choice of Venezuelan opposition leader Maria Corina Machado. That decision sparked debate, and observers will be looking to see how the committee navigates the current international landscape.

The Nobel Prizes were established through the will of Alfred Nobel, the Swedish inventor and philanthropist. Laureates receive their awards on December 10 each year, the anniversary of Nobel's death. The ceremonies take place in Stockholm and Oslo and are attended by Sweden's and Norway's royal families, with banquets held in the laureates' honour.

This year's medicine award places a spotlight on optogenetics, a technique that has become a cornerstone of modern neuroscience. By enabling precise control of nerve cells, it has allowed scientists to move beyond observation and into direct experimentation, testing how specific circuits drive behaviour and disease.

For Deisseroth, Hegemann and Nagel, the recognition caps years of dedicated research that began with fundamental questions about how light-sensitive proteins work and grew into a tool used by thousands of laboratories. Their discovery has not only deepened understanding of the healthy brain but also offers hope for new treatments for neurological and psychiatric conditions.

As the scientific community celebrates their achievement, the coming week will bring further announcements honouring breakthroughs in other fields. Yet the medicine prize serves as a reminder of how basic research, pursued across borders and disciplines, can yield insights that reshape entire fields of study and, ultimately, improve human lives.